HB Wealth Management’s GSK GSK Stock Holding History

HB Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.03M	Buy	19,731 +1,310	+7%	+$69.3K	0.01%	730
2026 Q1	$1.02M	Buy	18,421 +2,993	+19%	+$162K	0.01%	650
2025 Q4	$757K	Buy	15,428 +748	+5%	+$34.9K	﹤0.01%	723
2025 Q3	$634K	Buy	14,680 +2,397	+20%	+$93.6K	﹤0.01%	758
2025 Q2	$472K	Buy	12,283 +603	+5%	+$23K	﹤0.01%	763
2025 Q1	$452K	Buy	11,680 +2,329	+25%	+$85.3K	﹤0.01%	796
2024 Q4	$316K	Buy	+9,351	New	+$337K	﹤0.01%	793

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

HB Wealth Management's GSK Position: Q2 2026 in Review

HB Wealth Management increased its GSK (GSK) stake by 7.1% in Q2 2026, buying an estimated $69.3K and bringing the position to 19,731 shares worth $1.03M. The position accounts for 0.01% of the portfolio, ranked #730.

HB Wealth Management first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

HB Wealth Management held 19,731 shares of GSK worth $1.03M as of Q2 2026.
HB Wealth Management bought 1,310 GSK shares in Q2 2026, an estimated $69.3K.
GSK made up 0.01% of HB Wealth Management's portfolio in Q2 2026, its #730 holding.
HB Wealth Management first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.